Bladder cancer patient registry tracking long-term outcomes and tumor samples
Builds a registry of bladder cancer patients to study long-term outcomes and tumor tissue.
Plain-language title generated from the registry record
Registry title: Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Key facts
- Where
- Kansas City, United StatesSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who come to clinic with suspected bladder cancer or who already have a bladder cancer diagnosis. It builds a registry of information to study long term outcomes.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Suspected bladder cancer or a diagnosis of bladder cancer. No stage is named.
Main reasons for not taking part
- People who do not have suspected bladder cancer cannot join
Read by machine on 12 November 2026.
Where in United States
- University of Kansas Medical CenterKansas City, United StatesContact: Jane LadesmaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Kansas Medical Center
- Trial code
- NCT03413982
- Record updated
- 10 March 2026
- Original description
The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.Read full original descriptionShow less
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.
Inclusion: Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate; Patients can participate in any additional research studies during the patients' participation within this protocol.
Exclusion: Patients who do not have presumed bladder cancer will not be eligible.